Hers vs Zealthy: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Hers beats Zealthy overall, scoring 7.3/10 vs 7.2/10. Hers is more affordable at $199/mo vs $286/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose Zealthy for users who want the option to switch between compounded and b.

A side-by-side comparison of Hers and Zealthy covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Zealthy

#42 of 48

7.2/10

Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.

Visit Zealthy

Feature	Hers	Zealthy
Our Score	7.3/10	7.2/10
Starting Price	$199/mo	$286/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand	Users who want the option to switch between compounded and brand-name GLP-1s
Ranking	#35	#42

Pros & Cons Compared

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Zealthy

Pros

+Dedicated insurance coordinators handle prior authorizations — potentially bringing brand-name GLP-1 costs to $25/mo
+Multi-month supply options (3, 6, or 12 months) — unique convenience most monthly-shipping competitors can't match
+Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
+LegitScript certified with 4.5-star Review.io rating

Cons

−$135 membership fee on top of medication cost makes cash-pay total ~$286/mo for semaglutide — above average
−Young company (founded 2023) with a relatively small review base — less track record than established platforms
−Prescription products are non-refundable for any reason once ordered

Our Verdict

Hers edges out Zealthy with a score of 7.3/10 vs 7.2/10. If budget is your priority, Hers starts at $199/mo compared to Zealthy's $286/mo. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose Zealthy if you want: users who want the option to switch between compounded and brand-name glp-1s.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hers nor Zealthy feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review